Eli Lilly and Company
LLY
Below: live stock price for Eli Lilly and Company (LLY), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Eli Lilly and Company (LLY) trades at 1,139.59 USD on cryptodowns.
- Prev close
- $1,136.11
- Volume (24h)
- $810.81M
- Market cap
- $1.02T
- Currency
- USD
Score
Insufficient data
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 1,144.81 -0.11%
- +20 bars
- 1,143 -0.27%
- +60 bars
- 1,142.3 -0.33%
- +120 bars
- 1,142.28 -0.33%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.034 USD.
Interpretation
Price sits near the lower third of the recent range, trend is roughly flat.
Descriptive observation — not investment advice.
Price report
How this asset has actually moved over the last 252 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 35.5%
- Max drawdown
- -23.3%
- Below period high
- -11.3%
- Best day
- +10.33%
- Worst day
- -7.79%
- Up days
- 49%
- Current streak
- 1 up
- Typical day swing
- 2.9%
- Volume vs average
- -31%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 1,292.65 high → 1,079.22 low · 60 bars
- ResistanceFib +161.8% extensionnot reached1,637.98 USD+42.92% from current
- ResistanceFib +100% extensionnot reached1,506.08 USD+31.41% from current
- ResistanceFib +61.8% extensionnot reached1,424.55 USD+24.29% from current
- ResistanceFib +27.2% extensionnot reached1,350.7 USD+17.85% from current
- ResistanceFib 23.6% retracementtested 5×1,242.28 USD+8.39% from current
- ResistanceFib 38.2% retracementtested 19×1,211.12 USD+5.67% from current
- ResistanceFib 50% midpointtested 22×1,185.93 USD+3.47% from current
- ResistanceFib 61.8% retracementNearesttested 17×1,160.75 USD+1.28% from current
- Current1,146.11 USD
- SupportFib 78.6% retracementtested 9×1,124.89 USD-1.85% from current
- SupportFib −27.2% extensionnot reached1,021.17 USD-10.90% from current
- SupportFib −61.8% extensionnot reached947.3202 USD-17.35% from current
- SupportFib −100% extensionnot reached865.7899 USD-24.46% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Recent news
- Update: Twist Bioscience Shares Rise After Eli Lilly Drug Discovery DealMT Newswires37m ago
- Sector Update: Healthcare Stocks Rise Wednesday AfternoonMT Newswires1h ago
- Will AI Save the Pharma Industry Billions? Novo’s Anthropic Deal Is Betting on It.Barrons.com2h ago
- Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?Motley Fool2h ago
- Ginkgo Datapoints to Supply Discovery Data for Eli Lilly's TuneLab NetworkMT Newswires4h ago
- Billionaire Ray Dalio’s Bridgewater’s and Cathie Wood’s ARK Portfolios: 2 Stocks They Both OwnInsider Monkey4h ago
- Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab DataBusiness Wire4h ago
- Sector Update: Healthcare Stocks Edge Higher Pre-Bell WednesdayMT Newswires5h ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,655 USD-0.35%
- 7203.TToyota Motor Corporation3,016 USD-0.17%
- 9984.TSoftBank Group Corp.6,183 USD-1.53%
- 6758.TSony Group Corporation3,719 USD-0.16%
- 6861.TKeyence Corporation75,900 USD+0.32%
- NVDANVIDIA Corporation215.2125 USD+1.43%
- AAPLApple Inc.333.77 USD+0.73%
- GOOGLAlphabet Inc.345.435 USD+0.13%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.